QT dispersion in patients with end-stage renal failure and during hemodialysis

Journal of the American Society of Nephrology

Volumn 10, Issue 6, 1999, Pages 1297-1302

  Lorincz, Istán ^a   Mátyus, János ^a   Zilahi, Zsolt ^a   Kun, Csaba ^a   Karanyi, Zsolt ^a   Kakuk, György ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; POLYSULFONE; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DIALYSATE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART REPOLARIZATION; HEART VENTRICLE CONDUCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MALE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL;

EID: 0344655663     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Zucchelli P, Santoro A: Dialysis-induced hypotension: A fresh look at pathophysiology. Blood Purif 11: 981-985, 1993
2. Ritz E, Rambausek M, Mall G, Ruffman K, Mandelbaum A: Cardiac changes to uremia and their possible relation to cardiovascular instability on dialysis. Contrib Nephrol 78: 221-229, 1990
3. Henderson LW: Hemodynamic instability during hemodialysis. Kidney Int 30: 605-612, 1986
4. Heber ME, Lahari A, Thompson D, Raftery EB: Baroreceptor, not left ventricular dysfunction, is the cause of hemodialysis hypotension. Clin Nephrol 32: 79-86, 1989
5. Palmer F, Henrich WL: The effect of dialysis on left ventricular contractility. In: Cardiac Dysfunction in Chronic Uremia, edited by Parfrey PS, Harnett JD, Dordrecht, The Netherlands, Kluwer Academic, 1992, pp 171-186
6. Yellin EL, Nikolic S, Frater RWM: Left ventricular filling and diastolic function. Prog Cardiovasc Res 32: 247-271, 1990
7. London GM, Marchais SJ, Safar Me: Aortic and large artery compliance in end-stage renal failure. Kidney Int 37: 137-142, 1990
8. Kooman JP, Gladziwa U, Bocker G, van Bortel LMAB, van Hooff JP, Leunissen KML: Role of the venous system in hemodynamics during ultrafiltration and bicarbonate dialysis. Kidney Int 42: 718-726, 1992
9. Mujais SK, Ing T, Kjellstrand C: Acute complications of hemodialysis and their prevention and treatment. In: Replacement of Renal Function by Dialysis, 4th Ed., edited by Winchester JF, Washington, Kluwer Academic, 1995, pp 698-724
10. Bergonzi G, Paties C, Vassallo G, Zangrandi A, Poisetti PG, Ballochi S, Fontana F, Scarpioni L: Dextran deposits in tissues of patients undergoing haemodialysis. Nephrol Dial Transplant 5: 54-58, 1990
11. Richter AW, Hedin H: Dextran hypersensitivity. Immunol Today 3: 132-138, 1982
12. Better OS, Rubinstein I, Winaver JM, Knochel P: Mannitol therapy revisited (1940-1997). Kidney Int 51: 886-894, 1997
13. Aviram A, Pfau A, Czackes JW, Ullman TD: Hyperosmolality with hyponatremia caused by inappropriate administration of mannitol. Am J Med 42: 648-650, 1967
14. Dorman HR, Sondheimer JH, Cadnapaphornchai P: Mannitolinduced acute renal failure. Medicine (Baltimore) 69: 153-159, 1990
15. Conte G, Dal Canton A, Imperatore P, De Nicola L, Gigliotti G, Pisanti A, Memoli B, Fuiano G, Esposito C, Andreucci VE: Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 38: 301-307, 1990
16. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: Systemic review of randomised controlled trials. Br Med J 317: 235-240, 1998
17. Hankeln K, Radel C, Beez M, Laniewsky P, Bohmert F: Comparison of hydroxyethylstarch and lactated Ringer's solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studies. Crit Care Med 17: 133-135, 1989
18. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G: The effects of albumin versus hydroyethyl starch on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 83: 254-261, 1996
19. Weidler B, von Bormann B, Sommermeyer K, Lohmann E, Peil J, Hempelmann G: Pharmakokinetische Merkmal als Kriterien für den klinische Einsatz von Hydroxyethylstarke. Arnzheim-Forsch Drug Res 41: 494-498, 1991
20. Leunissen KML, Kouw P, Kooman JP, Cheriex EC, DeVries PM, Donker AJ, van Hooff JP: New techniques to determine fluid status in hemodialyzed patients. Kidney Int 43: S50-S56, 1993
21. van Kuijk WHM, Wirtz JJJM, Grave W, de Heer F, Menheere PPCA, van Hooff JP, Leunissen KML: Vascular reactivity during combined ultrafiltration-hemodialysis: Influence of dialysate sodium. Nephrol Dial Transplant 11: 323-328, 1995
22. van Kuijk WHM, Luik AJ, de Leeuw PW, van Hooff JP, Niemann FHM, Habets HML, Leunissen KML: Vascular reactivity during hemodialysis and isolated ultrafiltration: Thermal influences. Nephrol Dial Transplant 10: 1852-1858, 1995
23. Edge G, Morgan M: The Genius infrared tympanic thermometer: An evaluation for clinical use. Anaesthesia 48: 604-607, 1993
24. Maeda K, Morita H, Shizato T, Vega BV, Kobayakawa H, Ishihara T, Inagaki H, Igarashi I, Kitano T: Role of hypovolemia in dialysis-induced hypotension. Artif Organs 12: 116-121, 1988
25. Steuer RR, Harris DH, Conis JM: A new technique for monitoring hematocrit and circulating blood volume: Its application in renal dialysis. Dial Transplant 22: 260-265, 1993
26. Leypoldt JK, Cheung AK, Steuer RR, Harris DH, Conis JM: Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis J Am Soc Nephrol 6: 214-219, 1995
27. de Vries PMJM, Meijer JH, Vlaanderen K, Oe PL, Donker AJM, Schneider H: Measurement of transcellular fluid shift during haemodialysis. Part 2. In vitro and clinical evaluation. Med Biol Eng Comput 27: 152-158, 1989
28. Kurtin PS, Shapiro AC, Tomita H, Raizman D: Volume status and body composition of chronic dialysis patients: Utility of bioelectric impedance plethysmography. Am J Nephrol 10: 363-367, 1990
29. Penaz J: Photoelectric measurement of blood pressure, volume and flow in the finger. 10th International Conference of Medical and Biological Engineering, Dresden, 1973
30. Whitney RJ: The measurements of volume changes in human limbs. J Physiol 121: 1-27, 1953
31. Stevens J: Should we use the univariate or the multivariate approach? In: Applied Multivariate Statistics for the Social Sciences, Hillsdale, NJ, Lawrence Erlbaum Associates, 1992, pp 454-456
32. Daugirdas JT: Dialysis hypotension: A hemodynamic analysis. Kidney Int 39: 233-246, 1991
33. Kooman JP, Gladziwa U, Bocker G, van Bortel LMAB, van Hooff JP, Leunissen KML: Role of the venous system in hemodynamics during ultrafiltration and bicarbonate dialysis. Kidney Int 42: 718-726, 1992
34. Rodriquez M, Llach F, Pederson JA, Palma A: Changes in plasma oncotic pressure during isolated ultrafiltration. Kidney Int 21: 519-523, 1982
35. Kohler H, Zschiedrich H, Clasen R, Linfante A, Gamm H: Blutvolumen, kolloidosmotischer Druck und Nierenfunktion von Probanden nach Infusion mittelmolekularer 10% Hydroxyathylstarke 200/0.5 und 10% Dextran 40. Anaesthesist 31: 61-67, 1982
36. Quon CY: Clinical pharmacokinetics and pharmacodynamics of colloid plasma volume expanders. J Cardiothorac Anaesth 2[Suppl 1]: 13-23, 1988
37. Laxenaire MC, Charpentier C, Feldman L: Anaphylactoid reactions to colloid plasma substitutes: Frequency, risk factors, mechanisms. Ann Fr Anesth Reanim 13: 301-310, 1994
38. Warren BB, Durieux ME: Hydroxyethyl starch: Safe or not? Anesth Analg 79: 1034-1035, 1997
39. Schneeberger R, Allbegger K, Oberascher G, Miller K: Juckreiz: Eine nebenwirkung von Hydroxyethylstarke (HES)? HNO 38: 298-303, 1990
40. Gall H, Kaufmann R, von Ehr M, Shumann K, Sterry W: Persistierender Pruritis nach Hydroxyethylstarke-Infusionen. Hautarzt 44: 713-716, 1993
41. Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JM, Vermylen J, van Aken M, Mortelmans LA: Effects of 6% hydroxyethylstarch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg 81: 1235-1242, 1995
42. Ginz HF, Gottschall V, Schwarzkopf G, Walter K: Exzessive Gewebespeicherung von Kolloiden im retikuloendothelialen System. Anaesthesist 47: 330-334, 1998
43. Bothner M, Georgieff M, Vogt NH: Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: A randomized, controlled epidemiology study. Anesth Analg 86: 850-855, 1998
44. Grochenig E, Albegger K, Dieterich HJ, Franke RP, Gerlach E, Jurecka W, Kiesewetter H, Koch G, Ladurner G, Polz W, Schimetta W, Schneeberger R, Volgger R, Wilhelm HJ, Zelger J: Hydroxyethylstarch-related pruritis: A prospective multicentre investigation of 544 patients. Perfusion 11: 62-69, 1998
45. Steinhoff J, Mansky T, Reitz M, Schultz K, Sack K: Pharmakokinetik von Hydroxyethylstarke bei Patienten unter Haemodialyse, and Haemofiltration. Nieren- und Hochdruckkr 17: S411-S414, 1988